Anticoagulant potential of an antibody against factor VII

Journal of Surgical Research

Volumn 114, Issue 1, 2003, Pages 37-41

  Chu, Arthur J ^a,b   Mathews, Suresh T ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Surgery Dept   (United States)

Author keywords

Anti inflammation; Anticoagulant; FVII; Hypercoagulation; The extrinsic coagulation; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7 ANTIBODY; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANTICOAGULATION; ARTICLE; CATALYSIS; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; IN VIVO STUDY; INCUBATION TIME; PRIORITY JOURNAL; WESTERN BLOTTING;

EID: 0043235832     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-4804(03)00277-4     Document Type: Article

References (32)

1. Thomas R.H. Hypercoagulability syndromes. Arch. Intern. Med. 161:2001;2433.
2. Tufano A., Coppola A., Loffredo F., Garofano T., Celentano A., DiMinno G. Hypercoagulability and atherothrombosis clinical suggestions and perspectives . Haematologica. 86:2001;8.
3. Broze G.J. Jr. Tissue factor pathway inhibitor and the revised theory of coagulation. Annu. Rev. Med. 46:1995;103.
4. Gando S. Disseminated intravascular coagulation in trauma patients. Semin. Thromb. Haemost. 27:2001;585.
5. Hardaway R.M., Williams C.H., Vasquez Y. Disseminated intravascular coagulation in sepsis. Semin. Thromb. Hemost. 27:2001;577.
6. Astic M.E. Septic shock. Lancet. 352:1998;1501.
7. De Somer F., Van Belleghem Y., Case F., Francois K., Van Overbeke H., Arnout J., Taeymans Y., Van Nooten G. Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 123:2002;951.
8. Camerer E., Kolsto A.-B., Prydz H. Cell Biology of tissue factor, the principal indicator of blood coagulation. Thromb. Res. 81:1996;1.
9. Giesen P.L., Nemerson Y. Tissue factor on the loose. Semin Thromb Hemost. 26:2000;379.
10. Wildgoose P., Berkner K.L., Kisiel W. Synthesis, purification and characterization of an Arg 152-Glu site-directed mutant of recombinant human blood clotting factor VII. Biochemistry. 29:1990;3413.
11. Libby P., Simon D.I. Inflammation and thrombosis the clot thickens . Circulation. 103:2001;1718.
12. White B., Perry D. Acquired antithrombin deficiency in sepsis. Br. J. Haematol. 112:2001;26.
13. Esmon C.T. Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation. Crit. Care Med. 27:(7S):2001;S48.
14. Kaiser B., Hoppensteadt D.A., Fareed J. Tissue factor pathway inhibitor an update of potential implications in the treatment of cardiovascular disorders . Expert. Opin. Invest. Drug. 10:2001;1925.
15. Hirsh J., Anand S.S., Halperin J.L., Fuster V. Guide to anticoagulant therapy: heparin: a statement for healthcare professionals from the American Heart Association. Circulation. 103:2001;2994.
16. Dennis M.S., Eigenbrot C., Skelton N.J., Ultsch M.H., Santell L., Dwyer M.A., O'Connel M.P., Lazarus R.A. Peptide exosite inhibitors of FVIIa as anticoagulants. Nature. 404:2000;465.
17. Leadley R.J. Jr. Coagulation factor Xa inhibition biological background and rationale . Curr. Top. Med. Chem. 1:2001;151.
18. Kaplan K.L., Francis C.W. Direct thrombin inhibitors. Semin. Hematol. 39:2002;187.
19. Chu A.J., Wang Z.G., Raphael U.O. IV. Anticoagulant activity of compound 48/80 inhibition of factor VII activation in leukemia THP-1 monocytes . J. Cardiovasc. Pharmacol. 36:2000;649.
20. Chu A.J., Wang Z.G., Raicu M., Ramos N., Beydoun S. Protamine inhibits tissue factor-initiated extrinsic coagulation. Br. J. Haematol. 115:2001;392.
21. Pedersen A.H., Nordfang O., Norris F., Wiberg F.C., Christensen P.M., Moeller K.B., Meidahl-Pedersen J., Beck T.C., Norris K., Hedner U., Kisiel W. Recombinant human extrinsic pathway inhibitor production, isolation and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions . J. Biol. Chem. 265:1990;16786.
22. Schmidt R.J., Myers A.M., Gillham N.W., Boynton J.E. Immunological similarities between specific chloroplast ribosomal proteins from Chlamydomonas reinhardtii and ribosomal proteins from Escherichia coli. Mol. Biol. Evol. 1:1984;317.
23. Chu A.J., Wang Z.G., Nwobi O.I., Beydoun S. Blockade by ruthenium red of tissue factor-initiated coagulation. Br. J. Pharmacol. 133:2001;659.
24. Smariga P.E., Maynard J.R. Platelet effects on tissue factor and fibrinolytic inhibition of cultured human fibroblasts and vascular cells. Blood. 60:1982;140.
25. Ruf W., Edgington T.S. An anti-tissue factor monoclonal antibody which inhibits TF VIIa complex is a potent anticoagulant in plasma . Thromb. Haemost. 66:1991;529.
26. Levi M., Ten Cate H., Bauer K.A., Van der Poll T., Edgington T.S., Buller H.R., Van Devnter S.J.H., Hack C.E., Ten Cate J.W., Rosenberg R.D. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J. Clin. Invest. 93:1994;114.
27. Church W.R., Messier T.L., Tucker M.M., Mann K.G. An inhibitory monoclonal antibody to factor X that blocks prothrombin activation but not prothrombinase enzyme assembly. Blood. 72:1988;1911.
28. Rao L.V.M., Rapaport S. Activation of factor VII bound to tissue factor a key early step in the tissue factor pathway of blood coagulation . Proc. Natl. Acad. Sci. USA. 85:1988;6687.
29. Versteeg H.H., Peppelenbosch M.P., Spek C.A. The pleiotropic effects of tissue factor a possible role for factor VIIa-induced intracellular signalling? Thromb. Haemost. 86:2001;1453.
30. Senden N.H., Jeunhomme T.M., Heemskerk J.W., Wagenvood R., van't Veer C., Hemker H.C., Buurman W.A. Factor Xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells. J. Immunol. 161:1998;4318.
31. Kaplanski G., Fabrigoule M., Boulay V., Dinarello C.A., Bongrand P., Kaplanski S., Farnarier C. Thrombin induces endothelial type II activation in vitro IL-2 and TNF-alpha-independent IL-8 secretion and E-selectin expression . J. Immunol. 158:1997;5435.
32. Tezono K., Sarker K.P., Kikuchi H., Nasu M., Kitajima I., Maruyama I. Bioactivity of the vascular endothelial growth factor trapped in fibrin clots production of IL-6 and IL-8 in monocytes by fibrin clots . Haemostasis. 31:2001;71.